|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-9-21
|
|
pubmed:abstractText |
Alzheimer disease (AD) neuropathology is present in Down syndrome (DS) after age 35, but dementia onset varies from ages 40 to 70 years. Because of small sample sizes and nonuniform determination of dementia, previous studies produced differing results on the influence of APOE subtypes on AD in DS.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
331-6
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10430422-Adult,
pubmed-meshheading:10430422-Age of Onset,
pubmed-meshheading:10430422-Alzheimer Disease,
pubmed-meshheading:10430422-Apolipoproteins E,
pubmed-meshheading:10430422-Down Syndrome,
pubmed-meshheading:10430422-Genotype,
pubmed-meshheading:10430422-Humans,
pubmed-meshheading:10430422-Incidence,
pubmed-meshheading:10430422-Middle Aged,
pubmed-meshheading:10430422-Risk Factors,
pubmed-meshheading:10430422-Sex Factors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.
|
|
pubmed:affiliation |
The Laboratories for Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
